How does combined positron emission tomography and computed tomography (PET/CT) compare with CT and magnetic resonance imaging (MRI) for monitoring head and neck cancer?
Background: PET/CT is the most sensitive of the currently available standardized imaging modes and is widely used for tumor staging and assistance in identifying cancer metastatic to the cervical lymph nodes from a primary that has not been identified; however, false positives can be common. To date, no good data exist regarding the costs related to false positives on PET/CT.
Explore this issue:April 2014
Study design: Study of selected literature from contemporary publications on the use of PET/CT, interpreted by expert opinion.
Setting: Departments of Otolaryngology and Radiology, University of Pittsburgh School of Medicine.